Skip to main content
. Author manuscript; available in PMC: 2015 Jul 9.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Apr 11;17(10):1528–1536. doi: 10.1016/j.bbmt.2011.03.006

Figure 2.

Figure 2

Frequency distribution of estimated rates of recurrent aGVHD following IS taper. PBSCT = ablative conditioning, peripheral blood stem cells; BMT = ablative conditioning, bone marrow; MUD = ablative conditioning, unrelated donor peripheral blood stem cells; RIC = reduced-intensity conditioning, peripheral blood stem cells; post-resolved GVHD = recurrent aGVHD in setting of IS taper following prior successfully treated episode of aGVHD (P <.05 for comparisons between each group, with exception of the comparison of myeloablative PBSCT and RIC PBSCT).